Onconetix, Inc. Product Liability Contingency, Third Party Recovery, Percentage
Onconetix, Inc. (ONCO) reported Product Liability Contingency, Third Party Recovery, Percentage of 100.00% for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-06-12.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:ProductLiabilityContingencyThirdPartyRecoveryPercentage · last filed 2026-03-13
- Onconetix, Inc. product liability contingency, third party recovery, percentage for the quarter ending 2025-03-31 was 100.00%, a 185.71% increase year-over-year.
- Onconetix, Inc. product liability contingency, third party recovery, percentage for the quarter ending 2024-03-31 was 35.00%.
- Onconetix, Inc. product liability contingency, third party recovery, percentage for fiscal 2023 was 55.00%.
| Period end | Product Liability Contingency, Third Party Recovery, Percentage | Product Liability Contingency, Third Party Recovery, Percentage 3 month | Product Liability Contingency, Third Party Recovery, Percentage 9 month | Product Liability Contingency, Third Party Recovery, Percentage 12 month |
|---|---|---|---|---|
| 2025-03-31 | 100.00% 10-Q · filed 2025-06-12 | |||
| 2024-12-31 | 100.00% 10-K · filed 2026-03-13 | 100.00% 10-Q · filed 2025-11-13 | ||
| 2024-09-30 | 100.00% 10-Q · filed 2024-12-10 | |||
| 2024-03-31 | 35.00% 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | 55.00% 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |